These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23115071)

  • 1. Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran.
    Janghorbani M; Amini M
    Endokrynol Pol; 2012; 63(5):372-80. PubMed ID: 23115071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Metabolic Syndrome and Its Risk Factors among Type 2 Diabetes Clinic Attenders in Isfahan, Iran.
    Janghorbani M; Amini M
    ISRN Endocrinol; 2012; 2012():167318. PubMed ID: 22474593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in first degree relatives of patients with type 2 diabetes: Incidence and risk factors.
    Janghorbani M; Amini M
    Diabetes Metab Syndr; 2011; 5(4):201-6. PubMed ID: 25572763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Ann Nutr Metab; 2016; 68(1):19-25. PubMed ID: 26559166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of anthropometric indices in adolescence with the occurrence of the metabolic syndrome in early adulthood: Tehran Lipid and Glucose Study (TLGS).
    Barzin M; Asghari G; Hosseinpanah F; Mirmiran P; Azizi F
    Pediatr Obes; 2013 Jun; 8(3):170-7. PubMed ID: 23042576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus.
    Kim WY; Kim JE; Choi YJ; Huh KB
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():47-51. PubMed ID: 18296299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in type 2 diabetes mellitus in isfahan, iran: prevalence and risk factors.
    Janghorbani M; Amini M
    Metab Syndr Relat Disord; 2007 Sep; 5(3):243-54. PubMed ID: 18370778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
    Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
    Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
    Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Androgens and Sex Hormone-Binding Globulin in Women and Risk of Metabolic Syndrome and Type 2 Diabetes.
    Fenske B; Kische H; Gross S; Wallaschofski H; Völzke H; Dörr M; Nauck M; Keevil BG; Brabant G; Haring R
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4595-603. PubMed ID: 26445113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran.
    Janghorbani M; Amini M; Ghanbari H; Safaiee H
    Ophthalmic Epidemiol; 2003 Apr; 10(2):81-95. PubMed ID: 12660857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.
    Hosseini N; Talaei M; Dianatkhah M; Sadeghi M; Oveisgharan S; Sarrafzadegan N
    Metab Syndr Relat Disord; 2017 Sep; 15(7):354-362. PubMed ID: 28677982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of metabolic syndrome and metabolic syndrome risk factors in college-aged students.
    Dalleck LC; Kjelland EM
    Am J Health Promot; 2012; 27(1):37-42. PubMed ID: 22950924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
    Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study.
    Hajian-Tilaki K; Heidari B; Firouzjahi A; Bagherzadeh M; Hajian-Tilaki A; Halalkhor S
    Diabetes Metab Syndr; 2014; 8(3):170-6. PubMed ID: 25220921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2005 Oct; 70(1):71-80. PubMed ID: 16126125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women.
    Maharlouei N; Bellissimo N; Ahmadi SM; Lankarani KB
    Climacteric; 2013 Oct; 16(5):561-7. PubMed ID: 23157491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.